Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 10-day trial to continue exploring with full access.

Novartis responds to ongoing corruption investigations

Jaclyn Jaeger | February 12, 2018

Editor's Note: This post has been updated with a response from Novartis.

Greek prosecutors continue their investigation against Novartis, which is at the center of a bribery and corruption investigation concerning allegations that the Swiss pharmaceutical company paid bribes to politicians in exchange for fixing the prices of its drugs at artificially high prices and increasing its access to the Greek market.

Details of the investigation were not made public, but Parliament last week named ten politicians alleged to be involved, who held office between 2006 and 2015, Greek media outlet, AMNA, reported. The politicians were identified in a report submitted by Tasia Christodoulopoulou, head of Parliament’s transparency committee and a lawmaker for governing party, Syriza.

The named politicians are: